HIV-1–Associated Cognitive-Motor Disorders: A Research-Based Approach to Diagnosis and Treatment

No abstract is available for this paper.

• Publication year

  2000

• Venue

  CNS Spectrums

• Publication date

  2000-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1017/S1092852900007549PMID 18192940
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Central Nervous System Opportunistic Infections in HIV-1 Infection

  2000cited by this paper
• Cognitive Effects of HIV-1 Infection

  2000cited by this paper
• Nutritional Contributions to the CNS Pathophysiology of HIV-1 Infection and Implications for Treatment

  2000cited by this paper
• Dementia and the Neurovirulence of HIV-1

  2000cited by this paper
• A randomized controlled clinical trial of a bereavement support group intervention in human immunodeficiency virus type 1-seropositive and -seronegative homosexual men.

  1999cited by this paper
• Independent Evolution of HIV Type 1 in Different Brain Regions

  1999cited by this paper
• Executive function in depression: the role of performance strategies in aiding depressed and non-depressed participants

  1999cited by this paper
• Comprehensive classification of symptoms and signs reported among 218 patients with acute HIV-1 infection.

  1999cited by this paper
• Indinavir-based treatment of HIV-1 infected patients: efficacy in the central nervous system.

  1999cited by this paper
• Brief Communications Expedited Publication HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy

  1999cited by this paper
• Mortality risk in selenium-deficient HIV-positive children.

  1999cited by this paper
• Relation of JC virus DNA in the cerebrospinal fluid to survival in acquired immunodeficiency syndrome patients with biopsy‐proven progressive multifocal leukoencephalopathy

  1999cited by this paper
• Randomized trial of the platelet-activating factor antagonist lexipafant in HIV–associated cognitive impairment

  1999cited by this paper
• Alcohol use in HIV patients: what we don't know may hurt us

  1999cited by this paper
• Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team.

  1998cited by this paper
• Psychiatric Morbidity in HIV Patients

  1998cited by this paper
• Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment.

  1998cited by this paper
• Mild cognitive impairment and risk of mortality in HIV-1 infection.

  1998cited by this paper
• Psychoneuroimmunology : stress, mental disorders, and health

  1998cited by this paper
• A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment

  1998cited by this paper
• A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders.

  1998cited by this paper
• Parkinsonism with HIV infection

  1998cited by this paper
• The transport of the anti‐HIV drug, 2′,3′‐didehydro‐3′‐deoxythymidine (D4T), across the blood‐brain and blood‐cerebrospinal fluid barriers

  1998cited by this paper
• Visuospatial and affect recognition deficit in depression.

  1998cited by this paper
• A phase I/II trial of nimodipine for HIV-related neurologic complications

  1998cited by this paper
• Subtle neuropsychological impairment and minor cognitive-motor disorder in HIV-1 infection. Neuroradiological, neurophysiological, neuroimmunological, and virological correlates.

  1997cited by this paper
• HIV-1 proviral DNA load across neuroanatomic regions of individuals with evidence for HIV-1-associated dementia.

  1997cited by this paper
• Indinavir in cerebrospinal fluid of HIV-1-infected patients.

  1997cited by this paper
• Italian multicentre study of didanosine compassionate use in advanced HIV infection

  1997cited by this paper
• HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time

  1996cited by this paper
• Dextromethorphan-induced mania.

  1996cited by this paper
• Influence of risk group and zidovudine therapy on the development of HIV encephalitis and cognitive impairment in AIDS patients

  1996cited by this paper
• Peptide T in the treatment of painful distal neuropathy associated with AIDS

  1996cited by this paper
• Psychopathology in 90 consecutive human immunodeficiency virus-seropositive and acquired immune deficiency syndrome patients with mostly intravenous drug use history.

  1996cited by this paper
• Bereavement and HIV infection

  1996cited by this paper
• Changes in depressive symptoms as AIDS develops. The Multicenter AIDS Cohort Study.

  1996cited by this paper
• Pilot study of the efficacy of atevirdine in the treatment of AIDS dementia complex

  1996cited by this paper
• Hippocampal atrophy in recurrent major depression.

  1996cited by this paper
• Cognitive correlates of long-term cannabis use in Costa Rican men.

  1996cited by this paper
• Changes in depressive symptoms as AIDS develops

  1996cited by this paper
• Dopamine deficits in the brain: the neurochemical basis of parkinsonian symptoms in AIDS

  1996cited by this paper
• Neuropsychological effects of Interferon Alfa-n3 treatment in asymptomatic human immunodeficiency virus-1-infected individuals.

  1996cited by this paper
• Brain lesions in patients with AIDS: H-1 MR spectroscopy.

  1995cited by this paper
• Evidence of apoptotic cell death in HIV encephalitis.

  1995cited by this paper
• Suramin blocks the binding of interleukin-1 to its receptor and neutralizes IL-1 biological activities.

  1994cited by this paper
• Neuropsychological dysfunction in depression: the relationship to regional cerebral blood flow

  1994cited by this paper
• Tryptophan Concentrations Increase in Cerebrospinal Fluid and Blood after Zidovudine Treatment in Patients with HIV Type 1 Infection

  1994cited by this paper
• Cerebrospinal fluid dopamine in HIV‐1 infection

  1994cited by this paper
• 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.

  1993cited by this paper
• Increased mortality associated with vitamin A deficiency during human immunodeficiency virus type 1 infection.

  1993cited by this paper
• Zidovudine treatment of the AIDS dementia complex: Results of a placebo‐controlled trial

  1993cited by this paper
• Adrenal gland enlargement in major depression.

  1993cited by this paper
• Anticytokine strategies in the treatment of the systemic inflammatory response syndrome.

  1993cited by this paper
• Adrenal gland enlargement in major depression. A computed tomographic study.

  1992cited by this paper
• Peptide T Treatment of Cognitive Impairment in HIV-Positive Intravenous Drug Users

  1992cited by this paper
• Pentoxifylline in Cerebrovascular Dementia

  1992cited by this paper
• Tolerability of oral dextromethorphan in patients with a history of brain ischemia.

  1992cited by this paper
• Identification of Membrane Anchorage Domains of the HIV‐1 gp160 Envelope Glycoprotein Precursor

  1991cited by this paper
• A Health Status Questionnaire Using 30 Items From The Medical Outcomes Study: Preliminary Validation in Persons With Early HIV Infection

  1991cited by this paper
• Excitotoxicity and dopaminergic dysfunction in the acquired immunodeficiency syndrome dementia complex. Therapeutic implications.

  1991cited by this paper
• Relationship of serum copper and zinc levels to HIV-1 seropositivity and progression to AIDS.

  1991cited by this paper
• Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection. II. Standardized clinical assessment of current and lifetime psychopathology.

  1991cited by this paper
• Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus‐type 1 (HIV‐1) infection

  1991cited by this paper
• HTLV-I-associated leukemia/lymphoma in south Florida.

  1991cited by this paper
• Organic mental disorders in HIV-1 infection.

  1990influential reference
• Prevalence of psychiatric disorders among men infected with human immunodeficiency virus. A controlled study.

  1988cited by this paper
• Psychiatric disorders in HIV-spectrum illness.

  1988cited by this paper
• Cognitive impairment due to AIDS-related complex and its response to psychostimulants.

  1988cited by this paper
• Pathogenesis of infection with human immunodeficiency virus.

  1987cited by this paper
• Human Tumor and Immunodeficiency Viruses

  1987cited by this paper
• Suramin therapy in AIDS and related disorders. Report of the US Suramin Working Group.

  1987cited by this paper
• Lymphadenopathy-associated virus: from molecular biology to pathogenicity.

  1985cited by this paper
• Neuropsychological dysfunctions in unipolar nonpsychotic major depressions.

  1983cited by this paper

• HIV-1-Associated Neurocognitive Disorders in the HAART Era

  2009cites this paper